BAC
Bank of America Corporation
BAC has the edge over GAIN overall, supported by stronger fundamentals and stronger modeled upside.
GAIN
Gladstone Investment Corporation
GAIN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
GAIN Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
GAIN's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like GAIN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
GAIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 3.8x | $14.87 | — |
| Cheap | 3.9x | $15.39 | +3.5% |
| Fair | 5.6x | $22.05 | +48% |
| Expensive | 11x | $42.09 | +183% |
| Forward | 16x | $14.87 | — |
Historical ranges are pointers, not guarantees.
GAIN has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over GAIN on the outlook, with more favorable valuation and earnings expectations.
GAIN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect GAIN's revenue to grow, but its profitability to weaken.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
GAIN has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus GAIN up 161%.
GAIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.94 | -76% |
| Q4 2022 | $1.46 | -54% |
| Q3 2022 | $1.51 | -55% |
| Q2 2022 | $2.02 | -25% |
| Q1 2022 | $3.08 | +141% |
| Q4 2021 | $3.20 | +$3.68 |
| Q3 2021 | $3.35 | +$3.88 |
| Q2 2021 | $2.70 | +$3.09 |
| Q1 2021 | $1.28 | +$1.49 |
GAIN earned $3.94 per share over the past year, up 161% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 69% for GAIN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
GAIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $15.6M | -69% |
| Q1 2022 | $19.7M | -17% |
| Q4 2021 | $10.7M | -40% |
| Q3 2021 | $31.8M | +257% |
| Q2 2021 | $50M | +1711% |
| Q4 2020 | $17.7M | +14% |
GAIN's revenue has slid since its 2021 peak: $16M last quarter, down 69% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 77% | -17 points |
| Q1 2022 | 85% | -1.6 points |
| Q4 2021 | 97% | +11 points |
| Q3 2021 | 89% | +14 points |
| Q2 2021 | 94% | +93 points |
| Q1 2021 | 86% | N/A |
| Q4 2020 | 86% | +0.3 points |
| Q3 2020 | 74% | N/A |
GAIN's operating margin was 77% last quarter, down 17 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over GAIN on cash generation, producing positive trailing cash flow while its opponent burns cash.
GAIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$134.7M | -$74M |
| Q2 2026 | $8.1M | +$58.2M |
| Q1 2026 | $16.8M | -85% |
| Q4 2025 | -$7.6M | +$164.3M |
| Q3 2025 | -$60.7M | -196% |
| Q2 2025 | -$50.2M | -507% |
| Q1 2025 | $112.7M | +1850% |
| Q4 2024 | -$171.9M | -924% |
GAIN's free cash flow was −$117M over the past year, against −$170M the year before. Free cash flow isn't a meaningful measure for financial services companies like GAIN.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over GAIN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
GAIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +3.6% | +1.4M shares |
| 3 years | +18% | +6M shares |
| 5 years | +20% | +6.6M shares |
| Available history | +21% | +7M shares |
GAIN has 40M diluted shares, up 3.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | $94.4M |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | $57.5M |
| Q4 2020 | — |
| Q3 2020 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
GAIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 3.1x | Elevated |
| Q1 2022 | 2.3x | Moderate |
| Q4 2021 | 2.1x | Moderate |
| Q3 2021 | 2.4x | Moderate |
| Q2 2021 | 1.6x | Healthy |
| Q1 2021 | 3.5x | Elevated |
| Q4 2019 | -0.1x | Net Cash |
GAIN's net debt is about 3.1 years of its operating earnings (EBITDA), up from 1.6 years a year ago. Net leverage isn't a meaningful measure for financial services companies like GAIN.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
GAIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.9 | Neutral |
| Stochastic | 20.4 | Neutral |
GAIN's weekly RSI is 42 (neutral) and its Stochastic is 20 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
GAIN PE vs Financial Services Sector
| Metric | GAIN | Sector median | Relative |
|---|---|---|---|
| PE | 3.8x | 13x | 71% below |
| PE % | 14 | 63 | 49 pts below |
GAIN has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
GAIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.2 | 2% below |
| 20 week MA | $15.8 | 5.8% below |
| 50 week MA | $15.1 | 1.6% below |
| 100 week MA | $14.5 | 2.8% above |
| 200 week MA | $14.1 | 5.8% above |
GAIN has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
GAIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.5 | $10.1 | -25% |
| 2021 | $10.1 | $16.6 | +64% |
| 2022 | $16.6 | $12.8 | -23% |
| 2023 | $12.8 | $14.2 | +10% |
| 2024 | $14.2 | $13.2 | -7% |
| 2025 | $13.2 | $13.9 | +5.4% |
| 2026 YTD | $13.9 | $14.9 | +7.2% |
GAIN has the edge over BAC on returns for 2026, with the stronger performance.